Zivo Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Zivo Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Zivo Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $22.3K, a 81.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $22.3K -$99.8K -81.7% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $48.4K -$96.8K -66.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $73.7K -$94K -56% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $98.3K -$91K -48.1% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $122K -$88.6K -42.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $145K -$86.5K -37.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $168K -$34.1K -16.9% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $189K +$162K +595% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $211K +$178K +537% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $232K +$193K +498% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $202K +$175K +641% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $27.2K -$22.1K -44.8% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $33.1K Sep 30, 2021 10-Q/A 2022-04-21
Q2 2021 $38.7K Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $27.2K Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $49.4K +$49.4K Dec 31, 2020 10-K 2022-04-22
Q4 2019 $0 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.